Subscribe: MedPage Today Rheumatology
Added By: Feedage Forager Feedage Grade A rated
Language: English
anti tnf  anti  cme medpage  cme  damage  guidelines  medpage today  medpage  patients cme  patients  resistant  rheumatology  risk  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedPage Today Rheumatology

MedPage Today Rheumatology

Physicians...get the latest breaking news on Rheumatology. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.

Published: Sat, 10 Dec 2016 22:35:07 -0400


D.C. Week: 'Cures' Act Goes to President's Desk

Sat, 10 Dec 2016 12:00:00 -0400

(MedPage Today) -- Also, a push to ditch the ACA's Independent Payment Advisory Board

MedPAC to Lobby for Scratching ASC Update Again

Fri, 09 Dec 2016 17:45:00 -0400

(MedPage Today) -- Congress should require centers to submit cost data

New Psoriasis Guidelines Aimed at Improving Outcomes (CME/CE)

Fri, 09 Dec 2016 10:00:00 -0400

(MedPage Today) -- 'Treat-to-target' goals to better individualize, evaluate, adjust regimens

Guidelines Needed for Methadone Tx: The Pain Medicine News Report

Wed, 07 Dec 2016 18:00:00 -0400

(MedPage Today) -- Also, study finds EHRs take away from face-time with patients

Drug Use or Abuse? Patient Care & Rheumatology Network

Tue, 06 Dec 2016 18:30:00 -0400

(MedPage Today) -- Also, 411 on adult vaccinations

D.C. Week: Trump Taps Price for HHS; Medicaid Expert to Run CMS

Sat, 03 Dec 2016 12:00:00 -0400

(MedPage Today) -- Also, House passes 'Cures' bill by wide margin

Glucocorticoids Linked to Organ Damage in SLE (CME/CE)

Sat, 03 Dec 2016 11:00:00 -0400

(MedPage Today) -- Even a dose as low as 4.42 mg/day, which is not typically associated with damage, increases the risk

Methotrexate Greatly Underprescribed for U.S. RA Patients (CME/CE)

Fri, 02 Dec 2016 15:30:00 -0400

(MedPage Today) -- The staple DMARD should be utilized longer, at higher doses, and via subcutaneous delivery, researchers say

Slight, Nonsignificant CV Risk with Actemra vs Enbrel

Mon, 28 Nov 2016 15:29:34 -0400

(MedPage Today) -- Few events seen with either agent

IL-1 Blocking Agent Succeeds in Resistant FMF (CME/CE)

Mon, 28 Nov 2016 11:00:00 -0400

(MedPage Today) -- First randomized trial among colchicine-resistant patients

With No Increase in Heart Risk, Will You Prescribe Celebrex?

Mon, 28 Nov 2016 09:00:00 -0400

(MedPage Today) -- The cardiovascular risk cloud has been lifted -- will it make a difference?

Sarilumab Effective in RA After Failure of Anti-TNF Therapy (CME/CE)

Sat, 26 Nov 2016 15:00:00 -0400

(MedPage Today) -- Adverse event profile consistent with this and other IL-6 receptor blockers

ACR 2016: Treatment Advances Continue

Sat, 26 Nov 2016 11:00:00 -0400

(MedPage Today) -- Improvements in rheumatic conditions both common and rare

Common Drugs Boost Diabetes Risk in RA Patients (CME/CE)

Fri, 25 Nov 2016 15:00:00 -0400

(MedPage Today) -- Hydrochloroquine, abatacept associated with reduced risk

IL-6 Blocker Beats Anti-TNF in RA (CME/CE)

Tue, 22 Nov 2016 09:30:00 -0400

(MedPage Today) -- Sarilumab superior to adalimumab as monotherapy